- Location
biotech company
"-
Inocucor's Microbial Crop Accelerator Secures California Approval
Nov 17, 2016Inocucor Technologies’ microbial crop accelerator for farmers and greenhouse growers has been approved for use in California. Registration by the California Department of Food and Agriculture also includes certification for the ...
Tags: California Approval, Agriculture
-
Deinove to Collaborate with Processium on Carotenoid Ingredient
Nov 17, 2016French biotech company Deinove will collaborate with Processium to develop carotenoid separation and purification techniques at an industrial scale. Assisted by the French based engineering consultant, Deinove will produce and distribute ...
Tags: Deinove, Carotenoid Ingredient
-
Granalix Launches Pomegranate Oil-Based Food Additive
Oct 8, 2016Granalix BioTechnologies has commercially launched a patented pomegranate oil based food supplement which is claimed to prevent neurodegeneration diseases. Branded as GranaGard, the food additive is produced by Supherb and is priced at ...
-
Okanagan Specialty Fruits' Third Biotech Apple Variety Gets USDA Approval
Sep 29, 2016Arctic Fuji, a genetically modified non-browning apple variety developed by Okanagan Specialty Fruits (OSF), has been approved by the US Department of Agriculture's Animal and Plant Health Inspection Service (USDA APHIS). OSF, which is a ...
Tags: Arctic Fuji, OSF, USDA APHIS
-
DFI, Mitr Phol to Jointly Expand Natural Sweetener Production in Asia
Sep 28, 2016US based biotech company Dynamic Food Ingredients (DFI) and Mitr Phol Group have formed a strategic partnership to expand production of natural sweeteners and other products in Asia. Mitr Phol, Thailand’s biggest sugar and exporter, ...
-
Meiogenix Partners with Lesaffre to Develop Improved Industrial Yeast Strains
Jun 12, 2016French biotech company Meiogenix has entered into an agreement with Lesaffre to develop improved industrial yeast strains using Meiogenix’s recombination technologies. Meiogenix's PhoeniX technology helps in controlling the process ...
-
Biomaterials Market in Europe Poised for Growth
Aug 18, 2015The short-term outlook for biomaterials in coatings and related sectors in Europe has been looking grim in the wake of the fall in the oil price. However companies along the biomaterials value chain in the region are not overtly concerned. ...
Tags: biomaterials, coatings
-
Mutant Libraries Are a Powerful Tool for Creating a Protein with Desired Properties
Sep 23, 2014Mutant libraries are a powerful tool for creating a protein with desired properties. Mutant libraries constructed using the In vitro molecular optimization method, a very efficient means of generating mutant proteins with improved or novel ...
Tags: Mutant Libraries, Creative Biomart, Medicine
-
Potential Breakthrough Drug Might Come From Big Tobacco
Aug 1, 2014Big Tobacco, almost unbelievably, is lending a hand in the creation of a potential breakthrough drug, a new class of drugs that could dull grave psychiatric disorders, improve attention of ADHD afflicted children, repel Alzheimer's onset, ...
Tags: Agriculture, Tobacco, Ecigarette
-
Google Founders Downplay Healthcare Plans
Jul 7, 2014Will Google ever be a healthcare company? The answer to that question appears to be "not really," based on the tenor of a recent interview between Larry Page and Sergey Brin and investor Vinod Khosla. In that conversation, Khosla hinted ...
-
Novozymes Has Teamed up with The CKIA Under a Three-year Agreement
Dec 19, 2013Biotech company Novozymes has teamed up with the China Knitting Industry Association (CKIA) under a three-year agreement to promote the use of enzyme technology, with the aim of saving water and energy. As the Chinese textile industry ...
Tags: enzymes technology, China's Knitwear, Novozymes, CKIA, textile industry
-
A Multiple-sclerosis Drug Was Approved for Sale in Europe on Tuesday
Sep 22, 2013A multiple-sclerosis drug that was at the center of Sanofi SA's SAN.FR +1.12% $20 billion takeover battle for Genzyme Corp. three years ago was approved for sale in Europe on Tuesday, the drug's first regulatory approval world-wide. The ...
-
Marinomed Biotechnologie Has Licensed The Rights of Five Drugs
Jul 18, 2013Viennese biotech company Marinomed Biotechnologie has licensed the rights of five drugs to a global pharmaceutical firm for the Chinese market. The drugs include three antiviral nasal sprays against common cold, influenza and colds in ...
-
AOP Orphan Pharmaceuticals Has Announced The Spin-off of Its 80% Stake in Activartis
Jun 20, 2013AOP Orphan Pharmaceuticals has announced the spin-off of its 80% stake in Activartis, a Vienna-based biotech company, to a group of private investors. Activartis has developed dendritic cell-based technology for individualized tumor ...
Tags: AOP Orphan, Medicine
-
Sygnis Pharma Has Entered Into a Licence Agreement for The Distribution
May 21, 2013Spanish-German biotech company Sygnis Pharma has entered into a licence agreement for the distribution of a new amplification buffer with QIAGEN, a sample and assay technologies provider. This is the second agreement with QIAGEN within ...
Tags: Sygnis Pharma, Buffer to Qiagen
